Compare IMMR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMR | LFMD |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.8M | 218.1M |
| IPO Year | 1999 | 2012 |
| Metric | IMMR | LFMD |
|---|---|---|
| Price | $7.31 | $2.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 294.4K | ★ 777.5K |
| Earning Date | 09-14-2026 | 11-16-2026 |
| Dividend Yield | ★ 4.15% | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $35,013,000.00 | $12,468,578.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | N/A | $18.09 |
| P/E Ratio | $42.76 | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $5.25 | $2.60 |
| 52 Week High | $8.05 | $7.32 |
| Indicator | IMMR | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 37.48 |
| Support Level | $6.30 | $2.66 |
| Resistance Level | $7.65 | $3.46 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 38.74 | 6.11 |
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.